Development, implantation, in vivo elution, and retrieval of a biocompatible, sustained release subretinal drug delivery system

Journal of Biomedical Materials Research - Part A

Volumn 76, Issue 4, 2006, Pages 690-698

  Beeley, Nathan R F ^a,b   Stewart, Jay M ^a   Tano, Ryotaro ^a   Lawin, Laurie R ^b   Chappa, Ralph A ^b   Qiu, Guanting ^a   Anderson, Aron B ^b   De Juan, Eugene ^a   Varner, Signe E ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b SurModics Inc   (United States)

Author keywords

Angiogenesis; Biocompatible; Drug delivery; Ocular; Retina; Sirolimus; Sustained release; Triamcinolone

Indexed keywords

DISEASES; DRUG DELIVERY; DRUG PRODUCTS; IMPLANTS (SURGICAL); POLYMETHYL METHACRYLATES; TRANSPLANTATION (SURGICAL);

ANGIOGENESIS; SUSTAINED RELEASE; TRIAMCINOLONE;

BIOCOMPATIBILITY;

NITINOL; POLY(METHYL METHACRYLATE); RAPAMYCIN; TRIAMCINOLONE ACETONIDE; BIOMATERIAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BLEEDING; CATARACT; CONTROLLED STUDY; CORNEA EDEMA; DRUG DELIVERY SYSTEM; DRUG IMPLANT; INFLAMMATION; LENS IMPLANT; LENSECTOMY; NONHUMAN; RABBIT; RETINA DISEASE; SUSTAINED DRUG RELEASE; ANIMAL; RETINA;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; RABBITS; RETINA;

EID: 33745553974     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.30567     Document Type: Article

References (16)

1. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003;136:419-425.
2. Bourges JL, Gautier SE, Delie F, Bejjani RA, Jeanny JC, Gurny R, BenEzra D, Behar-Cohen FF. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci 2003;44:3562-3569.
3. Jaffe GJ, Yang CS, Wang XC, Cousins SW, Gallemore RP, Ashton P. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. Ophthalmology 1998;105: 46-56.
4. Gillies MC, Simpson JM, Billson FA, Luo W, Penfold P, Chua W, Mitchell P, Zhu M, Hunyor AB. Safety of an intravitreal injection of triamcinolone: Results from a randomized clinical trial. Arch Ophthalmol 2004;122:336-340.
5. Jaissle GB, Szurman P, Bartz-Schmidt KU. [Ocular side effects and complications of intravitreal triamcinolone acetonide injection]. Ophthalmologe 2004;101:121-128.
6. Verteporfin Roundtable Participants. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: Update. Retina 2005;25:119-134.
7. Food and Drug Administration (FDA). FDA approves new drug treatment for age-related macular degeneration. FDA News. P04-110, Rockville, MD: FDA; December 2004.
8. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-2816.
9. Beeley NRF, Rossi JV, Mello-Filho PAA, Mahmoud MI, Fujii GY, de Juan E, Varner SE. Fabrication, implantation, elution and retrieval of a steroid loaded polycaprolactone subretinal implant. J Biomed Mater Res A 2005;73:437-444.
10. Beeley NRF, Rossi JV, Mello-Filho PAA, Mahmoud MI, Fujii GY, de Juan E, Varner SE. Subretinal drug delivery using polymeric matrix loaded filaments. Invest Ophthalmol Vis Sci 2004;45:4557.
11. Shabalovskaya SA. Physicochemical and biological aspects of nitinol as a biomaterial. Int Mater Rev 2001;46:233-250.
12. Serruys PW, Regar E, Carter AJ. Stent development and local drug delivery. Br Med Bull 2001;59:227-248.
13. Serruys PW, Regar E, Carter AJ. Rapamycin eluting stent: The onset of a new era in interventional cardiology. Heart 2002;87: 305-307.
14. Food and Drug Administration (FDA). CYPHER™ sirolimus-eluting coronary stent on RAPTOR® over-the-wire delivery system or RAPTORRAIL® rapid exchange delivery system. P020026, Part 3, Miami Lakes, FL: FDA; April 2003.
15. Windecker S, Roffi M, Meier B. Sirolimus eluting stent: A new era in interventional cardiology? Curr Pharm Des 2003;9:1077-1094.
16. Smith TP. Why coat a stent with polymer? Radiology 2004;230: 1-2.